Researchers said if physicians gave heart failure patients a larger dose of angiotensin-receptor blockers, or ARBs, it would lead to fewer hospitalizations and deaths each year. A study of almost 4,000 patients given either 50 milligrams or 150 milligrams found death rates dropped 10% for those getting the higher dose.

Full Story:
USA Today

Related Summaries